Raghav Productivity Enhancers Limited

Basic Materials — Chemicals · NSE

₹1,804.00+₹54.60 (+3.12%)

DalalBaazaar Score

73 / 100

🟢 Good

Verdict

NEUTRAL

Risk

High

Driven by high debt relative to equity, negative free cash flow, small-cap size, which brings sharper price swings.

In simple words: Strong business and financial position, with both sales and profits growing well. Debt is the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 7:00 pm

Understanding the Business

Company site ↗

The 60-second version of Raghav Productivity Enhancers Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Raghav Productivity Enhancers Limited manufactures, trades in, and sells ramming mass and other quartz related items in India and internationally. It offers silica ramming mass and refractory products for use in creating linings for furnaces, incinerators, kilns, and reactors.

IndustryChemicals

SectorBasic Materials

Employees188

Annual revenue₹254 Cr

How does it make money?

Turns over ₹254 Cr a year. Of every ₹100 of sales, about ₹22 reaches shareholders as profit, with ₹30 left at the operating level before interest, tax and depreciation. Each of its 188 employees supports ₹1.35 Cr of revenue a year, the signature of a capital- or asset-led business.

Revenue / employee₹1.35 Cr

Who are its competitors?

The closest listed comparisons in its industry are PIDILITE INDUSTRIES LTD, SRF LTD, UPL LIMITED. These are the companies its valuation and returns are measured against elsewhere in this report.

Compared side by side in Peers ↓

What is its competitive advantage?The numbers suggest a real one

ROCE has stayed above 15% in every year available and stands at 27.7%. Returns that high normally get competed away; when they persist, something is protecting them, and its ROE of 28.4% against a peer median of 15.4% is consistent with that. What that something is — brand, scale, switching costs, regulation — the accounts cannot tell you.

Peer median ROE15.4%

What has been driving growth?

Growth has come mainly from selling more, rather than from keeping more of each sale. Over 3 years revenue moved +89% while net margin moved +15% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+89%

Margin effect+15%

DalalBaazaar Score

73/ 100

Good

Weighted across six categories. Every point is explained below.

✓ Beta of 0.75 — historically steadier than the index
✗ Small Cap: thinner liquidity and sharper drawdowns are normal
✗ High leverage magnifies any downturn in earnings
✗ Negative free cash flow means dependence on external funding

Quality vs. Valuation

Company Quality

83/ 100

Excellent

How good the business is, ignoring the share price entirely.

Valuation

39/ 100

Expensive

What you are being asked to pay, ignoring how good the business is.

A good business, but the price already reflects that. The quality is real; the question is whether you are overpaying for it today.

Historical Valuation

Current P/E

117.5x

2Y Median

151.5x

28 monthly readings · mean 161.5x · range 70.4x–261.9x

Sector Median

33.8x

median of 3 sector peers

🟢Current valuation is approximately 22% below its 2y median of 151.5x. Cheaper than its own history, which is worth a reason too: the market may be pricing in something the backward-looking numbers do not show.

⚠️Against its sector it trades 248% above the peer median of 33.8x.

vs. its own history

Cheap

151.5x median over 28 months · -22%

vs. sector peers

Expensive

33.8x median of 3 peers · +248%

vs. generic bands

Expensive

Above 35x

EV/EBITDA

110.2x

PEG

3.98

What's Good / What's Bad

🟢 What's Going Well7

Margins are improving
EBITDA margin is up from 27.0% to 29.6% over 3 years.
Debt is being paid down
Total debt is down 46% over 3 years.
Cash flow has turned positive
Free cash flow moved from negative to positive over 3 years.
Return on equity is rising
ROE has improved from 18.9% to 22.4%.
Return on capital is rising
ROCE has improved from 23.2% to 27.7%.
High return on capital employed
ROCE of 27.7% is the mark of a business that converts capital into profit efficiently.
Consistently profitable
Profitable in every one of the last 4 reported years.

🔴 What Needs Attention0

Nothing stands out as clearly deteriorating on the years of data available.

Red Flags

2 items require attention · 2 high

🔴High leverageFinancial
Debt/Equity of 1.63x — earnings must service borrowings before shareholders see anything.
🔴Inventory building faster than salesFinancial
Inventory up 214% against revenue up 89% — stock may not be moving.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Capital compounds at a high rate
ROCE of 27.7% means each rupee reinvested earns well above what capital costs. If the company can keep deploying at this rate, growth creates value rather than just consuming cash.
Margin expansion has further to run
EBITDA margin has risen from 27.0% to 29.6%. If that holds, profit compounds faster than sales and today's multiple looks cheaper in hindsight than it does now.
Deleveraging frees up earnings
Debt is down 46% over 3 years. Every rupee of interest not paid drops to the bottom line, so profit can grow even if revenue does not.
Priced below its own history
The stock trades 22% below its own median multiple. If the business performs as it has and simply re-rates back to normal, that gap is return on its own.
Earnings have proved durable
Profitable in every one of the last 4 reported years. Consistency lowers the risk that any single bad year is structural rather than cyclical.

🔴 Bear CaseWhat could go wrong?

Leverage amplifies any setback
Debt/Equity of 1.63x. Interest is payable whether or not the business has a good year.
A premium to the sector to defend
It trades 248% above the peer median. That premium needs a reason that persists, or it closes.
Size brings its own risk
Small Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.
Several serious flags at once
2 high-severity checks triggered. Individually each has an explanation; together they raise the chance that something structural is wrong rather than a one-off.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1Revenue growth stays above 18% a year✓ 23.5% CAGR
Latest reported year was 46.0%. The bar is set below the established compounding rate, so ordinary variation does not trip it.
2EBITDA margin holds above 28%✓ 29.6%
Two points below today's level — enough room for noise, tight enough to catch real compression.
3Free cash flow remains positive✓ ₹23 Cr
Profit that never becomes cash eventually stops being profit.
4Debt / EBITDA stays below 2x✓ 0.1x
The ratio lenders write covenants against; it survives a small or negative equity base, unlike Debt/Equity.
5ROCE stays above 25%✓ 27.7%
Falling returns on capital are usually competition arriving, and show up here before they reach the margin.

Investment Checklist

8 / 11 checks passed

✓ Strong return on equity (ROE ≥ 15%)
✓ Strong return on capital employed (ROCE ≥ 15%)
✓ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✗ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✓ Profit growing year-over-year
✗ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high
✓ Short-term technical trend isn't bearish

Price history

Quick Metrics

5 good · 2 neutral · 4 weak

Market Cap

₹8,284 Cr

Small Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

117.5x

Expensive

Expensive — verify against sector peers

P/B Ratio

29.43x

Rich

Steep premium to book — needs high, durable returns to justify

EPS (TTM)

₹15.35

Profitable

Profitable on a per-share basis

ROE

28.4%

Strong

Strong capital efficiency

ROCE

27.7%

Strong

Earns comfortably above its likely cost of capital

Debt/Equity

1.63x

High

High leverage

Revenue Growth (YoY)

46.0%

Healthy

Healthy top-line growth

Profit Growth (YoY)

56.0%

Healthy

Profits growing at a healthy clip

Dividend Yield

0.06%

Modest

Small cash return — most of the return has to come from the price

Free Cash Flow

-₹10 Cr

Cash burning

Spending more cash than the operations bring in

More Metrics

ROA

18.6%

Good

Assets are working hard

Operating Margin

28.2%

Good

Healthy core-business profitability

Net Margin

22.4%

Good

Strong bottom-line conversion

Current Ratio

5.15

Comfortable

Healthy short-term liquidity

Beta (vs Nifty)

0.75

Defensive

Steadier than the market

52W Range Position

90%

Near high

Near its 52-week high

Technical Snapshot

SMA 20 / SMA 50

1763.0 / 1665.9

Bullish alignment (short > long)

Price vs SMA 200

Above

Long-term uptrend

RSI (14)

59.6

Neutral momentum

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹135 Cr	₹133 Cr	₹197 Cr	₹254 Cr	+23.5%
EBITDA	₹36 Cr	₹40 Cr	₹54 Cr	₹75 Cr	+27.3%
EBITDA Margin	27.0%	30.2%	27.3%	29.6%	—
PAT (Net Profit)	₹25 Cr	₹26 Cr	₹37 Cr	₹55 Cr	+29.5%
EPS	₹5.5	₹2.83	₹8.05	₹11.94	+29.5%
ROE	18.9%	16.4%	19.1%	22.4%	—
ROCE	23.2%	21.0%	23.8%	27.7%	—
Total Debt	₹10 Cr	₹9 Cr	₹7 Cr	₹5 Cr	-18.5%
Free Cash Flow	-₹14 Cr	₹12 Cr	₹25 Cr	₹23 Cr	—

🟢 Revenue has grown at 23.5% a year over 3 years.

🟢 EBITDA has grown at 27.3% a year over 3 years.

🟢 EBITDA Margin has risen from 27.0% to 29.6% over 3 years (+2.6 pts).

🟢 PAT (Net Profit) has grown at 29.5% a year over 3 years.

🟢 EPS has grown at 29.5% a year over 3 years.

🟢 ROE has risen from 18.9% to 22.4% over 3 years (+3.5 pts).

🟢 ROCE has risen from 23.2% to 27.7% over 3 years (+4.4 pts).

🟢 Total Debt has shrunk at 18.5% a year over 3 years.

🟢 Free Cash Flow has turned positive, from -₹14 Cr to ₹23 Cr.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹284 Cr

Total Liabilities

₹39 Cr

Cash & Equivalents

₹7 Cr

Operating Cash Flow

₹37 Cr

Capex

-₹14 Cr

Shareholding (proxy)

Institutional Holding

0.0%

Insider Holding

76.9%

Corporate Actions

Dividend Rate

₹1

Ex-Dividend Date

19 Jun 2026

Peer Comparison

Company	P/E	ROE
PIDILITE INDUSTRIES LTD	57.8x	24.4%
SRF LTD	33.8x	15.4%
UPL LIMITED	21.5x	6.1%

Recent News

1 positive1 mixed4 general

Raghav Productivity Enhancers (RPEL) Share Price near 52-week high as RPEL trades at Rs 1,925

Univest, 14 Oct

Raghav Productivity Enhancers Q2FY27 Results: Net profit up 56% YoY to ₹21.6 crore

scanx.trade, 16 OctResults

🟢Potentially positiveReported improvement. Check whether it came from volume, price or a one-off item before treating it as a trend.

Raghav Productivity Enhancers (RPEL.NS) Edges Higher to ₹1,835.6 as Buyers Defend Key Support - Sentiment Extreme

https://www.siam.in/, 07 Oct

With EPS Growth And More, Raghav Productivity Enhancers (NSE:RPEL) Makes An Interesting Case

Simply Wall Street, 22 Aug

Rekha Jhunjhunwala likely exits this smallcap metal stock after 90% rally in 1 year. Do you own?

The Economic Times, 14 Jul

Raghav Productivity Enhancers forms JV with TRL Krosaki in Odisha

scanx.trade, 26 SeptPartnership

🟡Mixed / dependsA partnership, whose value depends entirely on terms that a headline will not carry. Worth reading the filing before assuming either way.

Watch Items

Cross-check against the company's latest quarterly filing / investor presentation before acting.

DalalBaazaar Thesis

StrongBusiness Quality · Growth · Profitability

MiddlingFinancial Health

WeakValuation · Risk

Points for each in the Score ↑

Good business, demanding price

The quality is real and the price already reflects it. Buying here is a bet that the business keeps compounding for long enough to grow into the multiple — which good businesses often do, but it removes the margin for error that a lower price would have given you. 2 high-severity red flags sit above this conclusion and should be read first.

All 5 tripwires holding · see Key things to watch ↑